HCM
LLY icon

Hilton Capital Management’s Eli Lilly LLY Stock Holding History

Hilton Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9M Buy
10,791
+153
+1% +$156K 0.88% 24
2026
Q1 		$9.79M Buy
10,638
+244
+2% +$247K 0.74% 32
2025
Q4 		$11.2M Buy
10,394
+30
+0.3% +$28.7K 0.84% 27
2025
Q3 		$7.91M Sell
10,364
-802
-7% -$597K 0.64% 38
2025
Q2 		$8.7M Sell
11,166
-4,069
-27% -$3.16M 0.69% 38
2025
Q1 		$12.6M Buy
15,235
+35
+0.2% +$29.1K 1.07% 19
2024
Q4 		$11.7M Sell
15,200
-1,870
-11% -$1.55M 1.02% 28
2024
Q3 		$15.1M Buy
17,070
+258
+2% +$232K 1.17% 18
2024
Q2 		$15.2M Buy
16,812
+4,012
+31% +$3.21M 1.28% 19
2024
Q1 		$9.96M Sell
12,800
-662
-5% -$471K 0.89% 36
2023
Q4 		$7.85M Buy
13,462
+895
+7% +$522K 0.84% 37
2023
Q3 		$6.75M Buy
+12,567
New +$6.48M 0.9% 33

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hilton Capital Management's LLY Position: Q2 2026 in Review

Hilton Capital Management increased its Eli Lilly (LLY) stake by 1.4% in Q2 2026, buying an estimated $156K and bringing the position to 10,791 shares worth $12.9M. The position accounts for 0.88% of the portfolio, ranked #24.

Hilton Capital Management first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. The position peaked at $15.2M in Q2 2024. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Hilton Capital Management held 10,791 shares of Eli Lilly worth $12.9M as of Q2 2026.
  • Hilton Capital Management bought 153 Eli Lilly shares in Q2 2026, an estimated $156K.
  • Eli Lilly made up 0.88% of Hilton Capital Management's portfolio in Q2 2026, its #24 holding.
  • Hilton Capital Management first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • Hilton Capital Management's Eli Lilly position peaked at $15.2M in Q2 2024.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.